Development and production of medicinal
products to treat socially important
diseases as a fully integrated site
International rapidly growing biotechnological company with all insulin blockbusters in its portfolio
Investment into technological development and creation of
modern pharmaceutical infrastructure
modern pharmaceutical infrastructure
Leadership in diabetology
Development of production of active
pharmaceutical substances
pharmaceutical substances
Our mission
By developing the technology of the industry, developing and producing effective medicines, we create a healthy future.
Values of the company
Ambition
these are ideas created by our brain that allow us to surpass ourselves
Passion
creates a fire in our heart
Responsibility
it's our hands that finish the job
History of the company
GEROPHARM was founded in 2001. Today GEROPHARM is a large and efficient business structure, one of the key players at the Russian pharmaceutical market and an expert of the professional community.
2001
Start of the release of original medicinal products – Cortexin®
and Retinalamin ®
and Retinalamin ®
2006
The technology
of insulin production was developed
of insulin production was developed
2011
Opening of its own
R&D Centre
R&D Centre
2013
Opening of the GEROPHARM plant
in the village of Obolensk (Moscow Region)
Start of release of generics.
in the village of Obolensk (Moscow Region)
Start of release of generics.
2014
Opening of biotechnological
unit laboratories in
R&D Centre
unit laboratories in
R&D Centre
2016
The company ranked top
in the Russian market of
human recombinant insulins.
Launch of Pineamin®
in the Russian market of
human recombinant insulins.
Launch of Pineamin®
2017
Phase 1 facilities commissioned
at Pushkin manufacturing plant
to produce API for original medicinal products
at Pushkin manufacturing plant
to produce API for original medicinal products
2018
Phase 2 facilities commissioned
at Pushkin manufacturing plant
to produce insulin API
at Pushkin manufacturing plant
to produce insulin API
2019
Development and release
of insulin bio analogues
as the Russian market
Initial supplies of insulins
to Venezuela and localisation
of insulin production in Kazakhstan
of insulin bio analogues
as the Russian market
Initial supplies of insulins
to Venezuela and localisation
of insulin production in Kazakhstan
2020
TOP-3 among the insulin manufacturers in Russia
Launch of original medicinal product Evodin®, insulins Rinsulin® Mix 30/70 and RinFast®
Winner of the Quality Award of the Government of the Russian Federation
Launch of original medicinal product Evodin®, insulins Rinsulin® Mix 30/70 and RinFast®
Winner of the Quality Award of the Government of the Russian Federation
2021
GLP Compliance Status is confirmed
Launch of educational project for patients “Academy of Diabetes”
Release of insulin analogue RinFast® Mix 30
Launch of educational project for patients “Academy of Diabetes”
Release of insulin analogue RinFast® Mix 30
2022
The company takes the first position
in the Russian insulin market
in the segments of its presence
Cuban GMP Certificate is received
in the Russian insulin market
in the segments of its presence
Cuban GMP Certificate is received
2023
A representative office of GEROPHARM
registered in Venezuela.
Arrangement of local insulin production facilities in Algeria
registered in Venezuela.
Arrangement of local insulin production facilities in Algeria
2024
Получение сертификата
Халяль на инсулины
Начало поставок
инсулинов в Марокко
Халяль на инсулины
Начало поставок
инсулинов в Марокко
Social Responsibility
Work in such a socially important industry as production of pharmaceutical products gives an understanding of the most urgent problems in healthcare. We are contributing to solving thereof together with public organizations, doctors and patients’ community and reporters.
2018 - CityAD - All rights reserved
Made in 